- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06077097
Traumatic Events in Childhood, Attachment, Pain Perception, Epigenetic Marks, Quality of Life and Resilience.
Traumatic Events in Childhood, Attachment, Pain Perception, Epigenetic Marks, Quality of Life and Resilience: When Psychological Dimensions Interfere With the Hospital Management of Pain
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
One in four French adults suffers from chronic pain (CP), making it one of the main causes of long-term disability and disease burden in France. Despite the various pain management plans, which have brought their share of improvements, CP remains extremely resistant to treatment, and its annual health costs represent a major national problem. Considering that 70% of CP patients remain severely undertreated, managed exclusively by general practitioners and CP specialists, there is an emerging need to implement more effective and cost-efficient interdisciplinary pain management programs, following a biopsychosocial framework for the management of pain. This framework integrates biological, psychological, and social measures and their interactions to highlight an individual's unique pain state.
The psychological concept of "adverse childhood experiences" (ACEs) may play a role in the development and maintenance of CP. Researchers point to a frequency-dependent relationship between ACEs and chronic conditions in adulthood, with a higher number of ACEs leading to more severe CP problems in adulthood. However, research is still in its infancy, and it cannot be concluded that there is a causal relationship between ACEs and the development of persistent pain.
It is, therefore, essential to consider several factors that may potentially mediate this relationship, such as the psychological concept of adult attachment style. The latter refers to the way relationships with others are formed, shaped in early childhood. Attachment patterns can be characterized along two dimensions: attachment anxiety (worry about the availability of others) and attachment avoidance (discomfort with proximity and interdependence). Insecure attachment patterns (high anxiety and/or avoidance) have been associated with the development of chronic conditions such as fatigue, medically unexplained CP, and migraines. Furthermore, in patients with CP, attachment anxiety is associated with increased pain. Experimental pain studies have also shown a positive relationship between attachment anxiety and pain. In contrast, the results concerning attachment avoidance are contradictory. Attachment patterns are of great importance for the current project, as CP management programs are usually based on patient-to-patient talk groups, and the medical devices are occupied by doctors and carers. Therefore, the medical discourse, as well as the discourse of peers (i.e. other patients), will not have the same impact or importance depending on whether patients have developed secure attachments or not.
Based on the evidence presented above, it seems that the psychological constructs of ACEs and attachment may open up new avenues for understanding individual differences in the context of CP management programs. The research is particularly interested in complementing this line of reasoning by investigating individual differences in various epigenetic markers and levels of resilience of individuals to better understand how potentially traumatic life events will have different effects on patients and their treatment effectiveness.
The project aims to develop a more inclusive framework to study the role of ACEs in patients' pain perception and overall quality of life throughout their pain treatment, exploring the potential mediating effect of attachment styles, resilience, and deoxyribonucleic acid (DNA) methylation levels. The project is innovative in its assessment of multiple genetic receptors through the application of an ancillary biological study and in its application of a longitudinal research design.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Lorraine,
-
Metz, Lorraine,, France, 57000
- Ur 4360 Apemac
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Have a chronic pain syndrome persisting for at least six months
- Have been referred to a chronic pain management programme at the Centre of evaluation and treatment of chronic pain at the "Belle- Isle" hospital (private hospital in Metz, France) or at the Pain Consultation of the Regional University Hospital of Nancy, France
- Be between 18 and 65 years old
- Be able to read and write in French (be able to understand the information and fill in the questionnaires independently)
- Agree to participate in the project and sign the consent form
Exclusion Criteria:
- Have received pain management in a specialised chronic pain facility (of any kind) during their lifetime
- Have physical, cognitive and/or linguistic deficiencies that make it impossible to fill in the questionnaires
- Have a psychiatric history (psychosis type)
- Have a drug or alcohol dependency
- Be a protected adult, under guardianship or curatorship
- Being pregnant or breastfeeding
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Observe the reported pain intensity and pain affect in individuals experiencing chronic pain
Time Frame: Baseline. Through study completion, an average of 1 year.
|
Pain intensity and pain affect will be measured using the Numerical Rating Scale (NRS).
The Numerical Rating Scale is typically an 11-point scale, with 0 representing "no pain" and 10 representing "the worst pain imaginable."
In the case of pain intensity, higher scores on the NRS indicate worse pain, with 10 being the most severe pain.
For pain affect, higher scores on the NRS may indicate more negative affective responses related to pain.
|
Baseline. Through study completion, an average of 1 year.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attachment Styles
Time Frame: Baseline. Through study completion, an average of 1 year.
|
The different Attachment Styles (AS) will be identified using the Experiences in Close Relationships-Revised Questionnaire (ECR-R).
It is a 36-item self-report questionnaire that assesses AS in romantic relationships.
It consists of two dimensions: attachment anxiety and attachment avoidance.
Participants rate each of the 36 statements using a 7-point likert scale which ranges from 1-strongly disagree to 7-strongly agree.
Interpretation: Higher scores indicate a worse outcome in terms of attachment-related anxiety/avoidance, reflecting greater insecurity in romantic relationships.
|
Baseline. Through study completion, an average of 1 year.
|
|
Adverse childhood experiences
Time Frame: Baseline. Through study completion, an average of 1 year.
|
The number of Adverse Childhood Experiences (ACEs) will be assessed using the Adverse Childhood Experiences International Questionnaire (ACE-IQ). The total number of ACEs to which the participant has been "exposed" is summed to create an ACE score ranging from 0 (no ACEs) to 13. A score of 0 ACEs means a low level of adversity and a score of 13 means a major level of adversity. |
Baseline. Through study completion, an average of 1 year.
|
|
Assess the Quality of Life of individuals experiencing chronic pain
Time Frame: Baseline. Through study completion, an average of 1 year.
|
Quality of life will be assessed using the SF-12 questionnaire.
Two summary scores are reported from the SF-12 - a mental component score (MCS-12) and a physical component score (PCS-12).
The scores may be reported as Z-scores (difference compared to the population average, measured in standard deviations).
The United States population average PCS-12 and MCS-12 are both 50 points.
The United States population standard deviation is 10 points.
So each 10 increment of 10 points above or below 50, corresponds to one standard deviation away from the average.
Higher scores on the SF-12 scale generally signify better physical and mental health, fewer limitations in daily activities, less pain, and a more positive perception of overall well-being.
Conversely, lower scores suggest poorer health, more limitations, more pain, and a less positive perception of well-being.
|
Baseline. Through study completion, an average of 1 year.
|
|
Pain cognitions
Time Frame: Baseline. Through study completion, an average of 1 year.
|
Pain cognitions, assessed using the Pain Beliefs and Perceptions Inventory (PBPI) The Pain Beliefs and Perceptions Inventory (PBPI) is a questionnaire comprising 16 items that assess individuals' beliefs about pain across four primary dimensions: mystery, permanence, constancy, and self-blame.
Respondents rate each item on a 4-point scale, ranging from -2 (strongly disagree) to 2 (strongly agree).
In summary, higher scores on these PBPI subscales reflect stronger beliefs and perceptions in the respective dimensions of pain.
Interpretation of these scores should consider the context of the study and the specific research questions or hypotheses being investigated.
|
Baseline. Through study completion, an average of 1 year.
|
|
Pain Interference
Time Frame: Baseline. Through study completion, an average of 1 year.
|
The impact of pain on daily behaviour, measured using the Concise Pain Questionnaire (CPQ).
The questionnaire assesses the degree of pain interference in seven daily activities using a Likert scale from 0 (no interference) to 10 (complete interference).
Higher scores indicate more significant pain-related disruption to these activities, while lower scores suggest minimal interference.
A minimum of four completed items out of seven is required to calculate the mean pain interference score, offering a concise measure of pain's impact on daily life.
|
Baseline. Through study completion, an average of 1 year.
|
|
Pain resilience
Time Frame: Baseline. Through study completion, an average of 1 year.
|
Pain resilience processes as measured by the Pain Resilience Scale modified version for chronic pain (PRS) This scale comprises 12 items and 2 factors measuring cognitive/affective positivity and behavioral perseverance respectively. Respondents rate their agreement with each item using a Likert scale ranging from 0 ("not at all") to 4 ("all the time"). Higher scores in the cognitive/affective factor indicate a greater perceived ability to maintain cognitive and emotional positivity despite severe or prolonged pain. Higher scores in the behavioral perseverance factor indicate a greater perceived ability to persist in various behaviors even when faced with prolonged or severe pain. |
Baseline. Through study completion, an average of 1 year.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Epigenetic measurements related to childhood adversity
Time Frame: Baseline. Through study completion, an average of 1 year.
|
The percentage of methylation of genes encoding the target regions of the OXTR receptor and the NR3C1 and FKBP5 genes from whole blood, saliva and oral cells, assessed by Methylated DNA Immunoprecipitation (MeDIP) assays in combination with PCR to map the location and determine the abundance of modified histones or variants in the genome.
|
Baseline. Through study completion, an average of 1 year.
|
|
Stress Measurement
Time Frame: Baseline. Through study completion, an average of 1 year
|
Stress measurement: cortisol concentration in blood by enzyme immunoassay (EIA)
|
Baseline. Through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: CYRIL CYRIL, Pr, UR 4360 APEMAC, UNIVERSITY OF LORRAINE
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-A02519-34
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
Clinical Trials on Biological samples
-
Meyer Children's Hospital IRCCSRecruiting
-
Imagine InstituteReference center for rare diseases (Rare Gynecologic Diseases)RecruitingMayer Rokitansky Kuster Hauser SyndromeFrance
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingRisk of Breast Cancer | Risk of Gynaecological Cancer | Risk of Colorectal Cancer | Risk of Upper Gastrointestinal Cancers | Risk of Hepatic Cancers | Risk of Lung Cancer | Risk of Skin Cancers Except Basal-cell Carcinomas | Risk of Head and Neck Cancers | Risk of Mesothelioma | Risk of Kidney Cancer | Risk... and other conditionsFrance
-
Centre Hospitalier Universitaire de BesanconNot yet recruiting
-
Centre Hospitalier Universitaire de NiceFrench Society of RheumatologyRecruiting
-
Centre Hospitalier Universitaire de BesanconCompleted
-
Centre Hospitalier Universitaire de BesanconCompletedChronic Myeloid LeukemiaFrance
-
University Hospital, MontpellierInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingMetastatic Castration-resistant Prostate CancerFrance
-
Centre Hospitalier Universitaire de BesanconRecruitingHead and Neck Cancer | Lung CancerFrance